Minoo J Moghaddam Selected Research

Lipids

12/2020	Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice.
1/2020	Biomimetic Gemcitabine-Lipid Prodrug Nanoparticles for Pancreatic Cancer.
1/2016	Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minoo J Moghaddam Research Topics

Disease

5	Neoplasms (Cancer) 01/2016 - 12/2002
2	Adenocarcinoma 12/2020 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2016
1	Melanoma (Melanoma, Malignant) 06/2014

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 12/2020 - 01/2016
2	Gemcitabine FDA Link 12/2020 - 01/2020
2	Apolipoprotein A-II (Apolipoprotein A2)IBA 12/2020 - 01/2016
2	ProdrugsIBA 12/2020 - 01/2020
2	Capecitabine (Xeloda)FDA Link 07/2011 - 05/2011
1	EmulsionsIBA 01/2016
1	HDL LipoproteinsIBA 01/2016
1	nasIBA 06/2014
1	Methotrexate (Mexate)FDA LinkGeneric 12/2002
1	Anti-HIV Agents (AIDS Drugs)IBA 12/2002
1	Chlorambucil (Leukeran)FDA Link 12/2002
1	PalmitatesIBA 12/2002

Therapy/Procedure

1	Therapeutics 06/2014
1	Drug Therapy (Chemotherapy) 05/2011